141 related articles for article (PubMed ID: 18953408)
1. Strong signature of natural selection within an FHIT intron implicated in prostate cancer risk.
Ding Y; Larson G; Rivas G; Lundberg C; Geller L; Ouyang C; Weitzel J; Archambeau J; Slater J; Daly MB; Benson AB; Kirkwood JM; O'Dwyer PJ; Sutphen R; Stewart JA; Johnson D; Nordborg M; Krontiris TG
PLoS One; 2008; 3(10):e3533. PubMed ID: 18953408
[TBL] [Abstract][Full Text] [Related]
2. Genetic linkage of prostate cancer risk to the chromosome 3 region bearing FHIT.
Larson GP; Ding Y; Cheng LS; Lundberg C; Gagalang V; Rivas G; Geller L; Weitzel J; MacDonald D; Archambeau J; Slater J; Neuberg D; Daly MB; Angel I; Benson AB; Smith K; Kirkwood JM; O'Dwyer PJ; Raskay B; Sutphen R; Drew R; Stewart JA; Werndli J; Johnson D; Ruckdeschel JC; Elston RC; Krontiris TG
Cancer Res; 2005 Feb; 65(3):805-14. PubMed ID: 15705877
[TBL] [Abstract][Full Text] [Related]
3. Association between germline variation in the FHIT gene and prostate cancer in Caucasians and African Americans.
Levin AM; Ray AM; Zuhlke KA; Douglas JA; Cooney KA
Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1294-7. PubMed ID: 17548701
[TBL] [Abstract][Full Text] [Related]
4. Haplotype-based association studies of IGFBP1 and IGFBP3 with prostate and breast cancer risk: the multiethnic cohort.
Cheng I; Penney KL; Stram DO; Le Marchand L; Giorgi E; Haiman CA; Kolonel LN; Pike M; Hirschhorn J; Henderson BE; Freedman ML
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1993-7. PubMed ID: 17035411
[TBL] [Abstract][Full Text] [Related]
5. Common genetic variation at PTEN and risk of sporadic breast and prostate cancer.
Haiman CA; Stram DO; Cheng I; Giorgi EE; Pooler L; Penney K; Le Marchand L; Henderson BE; Freedman ML
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):1021-5. PubMed ID: 16702386
[TBL] [Abstract][Full Text] [Related]
6. A major locus for hereditary prostate cancer in Finland: localization by linkage disequilibrium of a haplotype in the HPCX region.
Baffoe-Bonnie AB; Smith JR; Stephan DA; Schleutker J; Carpten JD; Kainu T; Gillanders EM; Matikainen M; Teslovich TM; Tammela T; Sood R; Balshem AM; Scarborough SD; Xu J; Isaacs WB; Trent JM; Kallioniemi OP; Bailey-Wilson JE
Hum Genet; 2005 Aug; 117(4):307-16. PubMed ID: 15906096
[TBL] [Abstract][Full Text] [Related]
7. Comparative genomic mapping of the bovine Fragile Histidine Triad (FHIT) tumour suppressor gene: characterization of a 2 Mb BAC contig covering the locus, complete annotation of the gene, analysis of cDNA and of physiological expression profiles.
Uboldi C; Guidi E; Roperto S; Russo V; Roperto F; Di Meo GP; Iannuzzi L; Floriot S; Boussaha M; Eggen A; Ferretti L
BMC Genomics; 2006 May; 7():123. PubMed ID: 16719907
[TBL] [Abstract][Full Text] [Related]
8. Molecular analysis of the FHIT gene in human prostate cancer.
Latil A; Bièche I; Fournier G; Cussenot O; Pesche S; Lidereau R
Oncogene; 1998 Apr; 16(14):1863-8. PubMed ID: 9583683
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor beta polymorphism is associated with prostate cancer risk.
Thellenberg-Karlsson C; Lindström S; Malmer B; Wiklund F; Augustsson-Bälter K; Adami HO; Stattin P; Nilsson M; Dahlman-Wright K; Gustafsson JA; Grönberg H
Clin Cancer Res; 2006 Mar; 12(6):1936-41. PubMed ID: 16551880
[TBL] [Abstract][Full Text] [Related]
10. [Mutations of fragile histidine triad gene in Peutz-Jeghers syndrome and canceration].
Zhao XR; Kang LC; Zhou YS; Jia YX; Chen Z; Kang SH; Li WM; Zhao M; Cui JT; Sun AL; Lu YY
Ai Zheng; 2003 Jan; 22(1):50-4. PubMed ID: 12561436
[TBL] [Abstract][Full Text] [Related]
11. [Association of fragile histidine triad gene (FHIT) with susceptibility to esophageal cancer. A preliminary study].
Li W; Wang X; Cheng G
Zhonghua Zhong Liu Za Zhi; 1998 Jul; 20(4):258-60. PubMed ID: 10920977
[TBL] [Abstract][Full Text] [Related]
12. Mutation analysis of the FHIT gene in bronchoscopic specimens from patients with suspected lung cancer.
Cecener G; Tunca B; Egeli U; Karadag M; Vatan O; Uzaslan E; Tolunay S
Tumori; 2008; 94(6):845-8. PubMed ID: 19267103
[TBL] [Abstract][Full Text] [Related]
13. Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk.
Sun J; Wiklund F; Zheng SL; Chang B; Bälter K; Li L; Johansson JE; Li G; Adami HO; Liu W; Tolin A; Turner AR; Meyers DA; Isaacs WB; Xu J; Grönberg H
J Natl Cancer Inst; 2005 Apr; 97(7):525-32. PubMed ID: 15812078
[TBL] [Abstract][Full Text] [Related]
14. Multiple SNPs in intron 7 of thyrotropin receptor are associated with Graves' disease.
Hiratani H; Bowden DW; Ikegami S; Shirasawa S; Shimizu A; Iwatani Y; Akamizu T
J Clin Endocrinol Metab; 2005 May; 90(5):2898-903. PubMed ID: 15741259
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms of methylenetetrahydrofolate reductase and promoter methylation of MGMT and FHIT genes in diffuse large B cell lymphoma risk in Middle East.
Siraj AK; Ibrahim M; Al-Rasheed M; Bu R; Bavi P; Jehan Z; Abubaker J; Murad W; Al-Dayel F; Ezzat A; El-Solh H; Uddin S; Al-Kuraya K
Ann Hematol; 2007 Dec; 86(12):887-95. PubMed ID: 17712558
[TBL] [Abstract][Full Text] [Related]
16. COX-2 gene promoter haplotypes and prostate cancer risk.
Panguluri RC; Long LO; Chen W; Wang S; Coulibaly A; Ukoli F; Jackson A; Weinrich S; Ahaghotu C; Isaacs W; Kittles RA
Carcinogenesis; 2004 Jun; 25(6):961-6. PubMed ID: 14754878
[TBL] [Abstract][Full Text] [Related]
17. ERCC4 associated with breast cancer risk: a two-stage case-control study using high-throughput genotyping.
Milne RL; Ribas G; González-Neira A; Fagerholm R; Salas A; González E; Dopazo J; Nevanlinna H; Robledo M; Benítez J
Cancer Res; 2006 Oct; 66(19):9420-7. PubMed ID: 17018596
[TBL] [Abstract][Full Text] [Related]
18. PSCA gene variants (rs2294008 and rs2978974) confer increased susceptibility of gallbladder carcinoma in females.
Rai R; Sharma KL; Misra S; Kumar A; Mittal B
Gene; 2013 Nov; 530(2):172-7. PubMed ID: 23988503
[TBL] [Abstract][Full Text] [Related]
19. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation.
Wali A; Srinivasan R; Shabnam MS; Majumdar S; Joshi K; Behera D
Mol Cancer Res; 2006 Feb; 4(2):93-9. PubMed ID: 16513840
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive evaluation of genetic variation in the IGF1 gene and risk of prostate cancer.
Johansson M; McKay JD; Stattin P; Canzian F; Boillot C; Wiklund F; Adami HO; Bälter K; Grönberg H; Kaaks R
Int J Cancer; 2007 Feb; 120(3):539-42. PubMed ID: 17096324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
